We are monitoring the impact of COVID-19 on Asia Pacific Next Generation Antibody Therapeutics Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 5231
Share on
Share on

Asia Pacific Next Generation Antibody Therapeutics Market Research Report - Segmented By Therapeutics, Technology & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis on Size, Share, Trends, Growth, Forecast | 2019 - 2024

Pulished: February, 2020
ID: 5231
Pages: 145

Asia Pacific Next Generation Antibody Therapeutics Market Size & Growth (2019 – 2024):

According to the report, the size of the Asia Pacific Next Generation Antibody Therapeutics Market size is valued at USD 0.77 billion in 2019 and is projected to grow at a CAGR of 14.9% to reach USD 1.53 billion by 2024 during the forecast period 2019-2024. It captures 20% of the global market.

Next generation antibody therapeutics have high efficiency and are more safe. Rapid advancements in monoclonal antibodies technology is the reason for this. These advances have improved bifunctional properties, decreased functional size along with immunogenicity. Several medical conditions like cancer; autoimmune diseases etc. are treated using these technologies because of its enhanced properties.

Rising number of cases of chronic diseases, rapid advancements in technology, higher investment in R&D and increasing healthcare expenditure are the primary drivers of market growth. On the other hand, strict administrative guidelines and regulatory requirements and inordinate delays in approval for new drugs along with their high costs are the primary restraints of market growth.

Asia Pacific Next-Generation Antibody Therapeutics Market has been segmented and sub-segmented into the following categories

  • By Therapeutics: Oncology and Autoimmune/Inflammatory Diseases
  • By Technology: Antibody-Drug Conjugates (ADCs), Bispecific Antibodies (BsAbs), Fc Engineered Antibodies, Antibody Fragments and Antibody-like Proteins, and Biosimilar Antibody Products.
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC.

On the basis of region, the Asia Pacific is likely to be the fastest growing market with the highest CAGR in the forecast period. Economic boom in the emerging economies of India and China are the reasons for this.

Top Companies dominating the Asia Pacific Next Generation Antibody Therapeutics Market include Roche, Seattle Genetics, Takeda, Dyax Corp., and Immunogen, Amgen, Inc., Biogen, Kyowa Hakko Kirin Co., Ltd., AstraZeneca, Pfizer, Inc., and Xencor, Inc.

1. Introduction          

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods   

                1.4 General Study Assumptions                

2. Research Methodology                    

                2.1 Introduction        

                2.2 Research Phases                      

         2.2.1 Secondary Research           

         2.2.2 Primary Research 

         2.2.3 Econometric Modelling      

         2.2.4 Expert Validation  

                2.3 Analysis Design  

                2.4 Study Timeline   

3. Overview                

                3.1 Executive Summary                

                3.2 Key Inferences  

                3.3 Epidemiology       

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)             

                4.1 Market Drivers   

                4.2 Market Restraints                    

                4.3 Key Challenges  

                4.4 Current Opportunities in the Market       

5. Market Segmentation

                5.1 Technology                 

         5.1.1 Introduction           

         5.1.2 Antibody-Drug Conjugates (ADCs)               

         5.1.3 Bispecific Antibodies (BsAbs)          

         5.1.4 Fc Engineered Antibodies 

         5.1.5 Antibody Fragments and Antibody-like Proteins    

         5.1.6 Biosimilar Antibody Products          

         5.1.7 Y-o-Y Growth Analysis, By Technology        

         5.1.8 Market Attractiveness Analysis, By Technology      

         5.1.9 Market Share Analysis, By Technology        

                5.2 Therapeutic Application 

         5.2.1 Introduction           

         5.2.2 Oncology 

         5.2.3 Autoimmune/Inflammatory Diseases         

         5.2.4 Y-o-Y Growth Analysis, By Therapeutic Application               

         5.2.5 Market Attractiveness Analysis, By Therapeutic Application             

         5.2.6 Market Share Analysis, By Therapeutic Application               

6. Geographical Analysis

                6.1 Introduction        

         6.1.1 Regional Trends    

         6.1.2 Impact Analysis     

         6.1.3 Y-o-Y Growth Analysis        

  6.1.3.1 By Geographical Area

  6.1.3.2 By Technology

  6.1.3.3 By Therapeutic Application

         6.1.4  Market Attractiveness Analysis     

  6.1.4.1 By Geographical Area

  6.1.4.2 By Technology

                    6.1.4.3 By Therapeutic Application

         6.1.5  Market Share Analysis      

  6.1.5.1 By Geographical Area

  6.1.5.2 By Technology

  6.1.5.3 By Therapeutic Application

                6.2 China      

                6.3 India       

                6.4 Japan     

                6.5 South Korea        

                6.6 Australia     

                6.7 Rest of APAC                 

7. Strategic Analysis                

                7.1 PESTLE analysis  

         7.1.1 Political     

         7.1.2 Economic 

         7.1.3 Social         

         7.1.4 Technological         

         7.1.5 Legal          

         7.1.6 Environmental       

                7.2 Porter’s Five analysis       

         7.2.1 Bargaining Power of Suppliers        

         7.2.2 Bargaining Power of Consumers    

         7.2.3 Threat of New Entrants     

         7.2.4 Threat of Substitute Products and Services              

         7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                 

                8.1 Roche    

         8.1.1 Overview 

         8.1.2 Product Analysis   

         8.1.3 Financial analysis  

         8.1.4 Recent Developments       

         8.1.5 SWOT analysis       

         8.1.6 Analyst View          

                8.2 Seattle Genetics

                8.3 Takeda  

                8.4 Dyax Corp.                  

                8.5 Immunogen        

                8.6 Amgen, Inc.         

                8.7 Biogen   

                8.8 Kyowa Hakko Kirin Co., Ltd.                 

                8.9 AstraZeneca        

                8.10 Pfizer, Inc.                

9. Competitive Landscape                    

                9.1 Market share analysis     

                9.2 Merger and Acquisition Analysis

                9.3 Agreements, Collaborations, and Joint Ventures  

                9.4 New Product Launches  

10. Market Outlook and Investment Opportunities                  

Appendix                    

                a) List of Tables                

                b) List of Figures       

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of product type By Technology  market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Next Generation Antibody Therapeutics Market By Technology, From 2019-2024 ( USD Billion )
  2. Asia Pacific Antibody-Drug Conjugates (ADCs) Market By Region, From 2019-2024 ( USD Billion )
  3. Asia Pacific Bispecific Antibodies (BsAbs) Market By Region, From 2019-2024 ( USD Billion )
  4. Asia Pacific Fc Engineered Antibodies Market By Region, From 2019-2024 ( USD Billion )
  5. Asia Pacific Antibody Fragments and Antibody-like Proteins Market By Region, From 2019-2024 ( USD Billion )
  6. Asia Pacific Biosimilar Antibody Products Market By Region, From 2019-2024 ( USD Billion )
  7. Asia Pacific Next Generation Antibody Therapeutics Market By Therapeutic Application, From 2019-2024 ( USD Billion )
  8. Asia Pacific Oncology Market By Region, From 2019-2024 ( USD Billion )
  9. Asia Pacific Autoimmune/Inflammatory Diseases Market By Region, From 2019-2024 ( USD Billion )
  10. Japan Next Generation Antibody Therapeutics Market By Technology, From 2019-2024 ( USD Billion )
  11. Japan Next Generation Antibody Therapeutics Market By Therapeutic Application, From 2019-2024 ( USD Billion )
  12. China Next Generation Antibody Therapeutics Market By Technology, From 2019-2024 ( USD Billion )
  13. China Next Generation Antibody Therapeutics Market By Therapeutic Application, From 2019-2024 ( USD Billion )
  14. India Next Generation Antibody Therapeutics Market By Technology, From 2019-2024 ( USD Billion )
  15. India Next Generation Antibody Therapeutics Market By Therapeutic Application, From 2019-2024 ( USD Billion )
  16. Australia Next Generation Antibody Therapeutics Market By Technology, From 2019-2024 ( USD Billion )
  17. Australia Next Generation Antibody Therapeutics Market By Therapeutic Application, From 2019-2024 ( USD Billion )
  18. South Korea Next Generation Antibody Therapeutics Market By Technology, From 2019-2024 ( USD Billion )
  19. South Korea Next Generation Antibody Therapeutics Market By Therapeutic Application, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample